Chat with us, powered by LiveChat


Saama’s Latest Funding Covered by Endpoints News

Saama’s recent $40M funding from Perceptive Advisors was covered by Endpoints News in an article reviewing Saama’s role in the adoption of artificial intelligence to speed up drug discovery and development. This article asserts that, “Optimization and efficiency are goals that everyone working in R&D can rally around, and AI promises to be a tool that…

Read More

Saama Closes $40 Million Financing with Perceptive Advisors to Drive Disruption in Clinical Analytics and Drug Development

CAMPBELL, CA – (March 25, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced that it has closed a $40 million financing with Perceptive Advisors. The new funding will be used to support the expansion of Saama’s Life Science Analytics Cloud (LSAC), an AI-powered platform disrupting the planning, designing and…

Read More

Saama Announced as a Finalist in Clinical Trial Process Innovation Category for 2019 Clinical & Research Excellence Awards

CAMPBELL, CA – (February 25, 2019) – Saama Technologies, Inc., a leading data analytics company, has been named a finalist in the Clinical Trial Process Innovation category for the 2019 Clinical & Research Excellence (CARE) Awards, which recognize outstanding work across the global clinical research enterprise. Saama was selected as a CARE Awards finalist in…

Read More

Saama VP, Malaikannan Sankarasubbu, Interviewed by Outsourcing-Pharma

Saama VP of AI Research, Malaikannan Sankarasubbu , was interviewed at SCOPE 2019 by Outsourcing-Pharma on the topic of  natural language processing as a solution to pharma’s “big text problem.” In the article, he is quoted, “Pharma has a lot of unstructured text, and the surface of this data has hardly been scratched in terms…

Read More

New LSAC Capabilities Covered by Outsourcing-Pharma

Saama’s new AI-based capabilities for the Life Science Analytics Cloud, Virtual Assistant/AI, Operational and Financial Risk Mitigation, and Drug Efficacy and Patient Safety Analytics, are featured in this article from Outsourcing-Pharma: “With the industry continuing to adopt AI across various aspects of the business, Saama has voiced it’s commitment to deploying the technology in a targeted…

Read More

Saama Unveils New Capabilities for Award-Winning Life Science Analytics Cloud at SCOPE

CAMPBELL, CA – (February 18, 2019) – Saama Technologies, Inc., a leading data analytics company, today unveiled three new, machine learning-based capabilities that extend the existing functionality of its award-winning Life Science Analytics Cloud (LSAC). Saama announced the addition of these state-of-the-art programs infused with artificial intelligence (AI) — Virtual Assistant/AI, Operational and Financial Risk…

Read More

Saama Partners With The Leukemia & Lymphoma Society to Advance Study Operations for the Beat AML Master Trial to Provide Clinical Data Analytics

CAMPBELL, CA – (February 18, 2019) – Saama Technologies, Inc., a leading data analytics company, announced a new partnership with The Leukemia & Lymphoma Society (LLS), the world’s largest nonprofit dedicated to fighting blood cancers, to accelerate the development of novel acute myeloid leukemia (AML) therapies through its unprecedented Beat AML® Master Clinical Trial. LLS…

Read More

Clinical Epidemiologist, Mathematician, Open Science & Blockchain Enthusiast Dr. Mehdi Benchoufi Joins Saama Advisory Board

CAMPBELL, CA — (June 18, 2018) – Saama Technologies, Inc., a leading big data and advanced analytics solutions company, today announced that Mehdi Benchoufi, M.D., Assistant Professor in the Clinical Epidemiology Center at Hôtel-Dieu Hospital, University Paris Descartes, has joined its Board of Advisors (BOA). Dr. Benchoufi focuses on interfaces between clinical research and open technologies, with…

Read More

Related Posts